RESUMO

Background: The number of antiviral studies using plant extracts has increased in the last decades, and the results have shown that plants are potential sources of compounds that are able to inhibit and/or decrease viral infections. The selection of these plants by ethnopharmacological criteria increases the probability of fi nding new substances with signifi cant pharmacological and biological activities. Hence, Brazil has an advantage in this area due to its extensive biodiversity and ethnological diversity. Guettarda angelica is a plant from the Brazilian Caatinga region the roots of which are popularly used for various therapeutic purposes, including veterinary use. The aim of this work was to investigate the in vitro antiviral activity of extracts of plant parts from G. angelica against three animal herpesviruses: bovine (BoHV-1), suid (SuHV-1) and equine (EHV-1) herpesviruses type 1.Materials, Methods & Results: The extracts of roots, leaves and seeds of G. angelica were initially screened for in vitro antiviral activity against these herpesviruses using the virus yield reduction assay. The MDBK cells were used in assays with BoHV-1 and SuHV-1, and the Vero cells with EHV-1. For these assays, the cells previously treated with the extracts in non-cytotoxic concentrations were inoculated with logarithmic dilutions of each virus. The viral inhibitory activity of extracts

Background: The number of antiviral studies using plant extracts has increased in the last decades, and the results have shown that plants are potential sources of compounds that are able to inhibit and/or decrease viral infections. The selection of these plants by ethnopharmacological criteria increases the probability of fi nding new substances with signifi cant pharmacological and biological activities. Hence, Brazil has an advantage in this area due to its extensive biodiversity and ethnological diversity. Guettarda angelica is a plant from the Brazilian Caatinga region the roots of which are popularly used for various therapeutic purposes, including veterinary use. The aim of this work was to investigate the in vitro antiviral activity of extracts of plant parts from G. angelica against three animal herpesviruses: bovine (BoHV-1), suid (SuHV-1) and equine (EHV-1) herpesviruses type 1.Materials, Methods & Results: The extracts of roots, leaves and seeds of G. angelica were initially screened for in vitro antiviral activity against these herpesviruses using the virus yield reduction assay. The MDBK cells were used in assays with BoHV-1 and SuHV-1, and the Vero cells with EHV-1. For these assays, the cells previously treated with the extracts in non-cytotoxic concentrations were inoculated with logarithmic dilutions of each virus. The viral inhibitory activity of extracts

RESUMO

Background: The number of antiviral studies using plant extracts has increased in the last decades, and the results have shown that plants are potential sources of compounds that are able to inhibit and/or decrease viral infections. The selection of these plants by ethnopharmacological criteria increases the probability of fi nding new substances with signifi cant pharmacological and biological activities. Hence, Brazil has an advantage in this area due to its extensive biodiversity and ethnological diversity. Guettarda angelica is a plant from the Brazilian Caatinga region the roots of which are popularly used for various therapeutic purposes, including veterinary use. The aim of this work was to investigate the in vitro antiviral activity of extracts of plant parts from G. angelica against three animal herpesviruses: bovine (BoHV-1), suid (SuHV-1) and equine (EHV-1) herpesviruses type 1.Materials, Methods & Results: The extracts of roots, leaves and seeds of G. angelica were initially screened for in vitro antiviral activity against these herpesviruses using the virus yield reduction assay. The MDBK cells were used in assays with BoHV-1 and SuHV-1, and the Vero cells with EHV-1. For these assays, the cells previously treated with the extracts in non-cytotoxic concentrations were inoculated with logarithmic dilutions of each virus. The viral inhibitory activity of extracts

Background: The number of antiviral studies using plant extracts has increased in the last decades, and the results have shown that plants are potential sources of compounds that are able to inhibit and/or decrease viral infections. The selection of these plants by ethnopharmacological criteria increases the probability of fi nding new substances with signifi cant pharmacological and biological activities. Hence, Brazil has an advantage in this area due to its extensive biodiversity and ethnological diversity. Guettarda angelica is a plant from the Brazilian Caatinga region the roots of which are popularly used for various therapeutic purposes, including veterinary use. The aim of this work was to investigate the in vitro antiviral activity of extracts of plant parts from G. angelica against three animal herpesviruses: bovine (BoHV-1), suid (SuHV-1) and equine (EHV-1) herpesviruses type 1.Materials, Methods & Results: The extracts of roots, leaves and seeds of G. angelica were initially screened for in vitro antiviral activity against these herpesviruses using the virus yield reduction assay. The MDBK cells were used in assays with BoHV-1 and SuHV-1, and the Vero cells with EHV-1. For these assays, the cells previously treated with the extracts in non-cytotoxic concentrations were inoculated with logarithmic dilutions of each virus. The viral inhibitory activity of extracts

RESUMO

Background: The number of antiviral studies using plant extracts has increased in the last decades, and the results have shown that plants are potential sources of compounds that are able to inhibit and/or decrease viral infections. The selection of these plants by ethnopharmacological criteria increases the probability of fi nding new substances with significant pharmacological and biological activities. Hence, Brazil has an advantage in this area due to its extensive biodiversity and ethnological diversity. Guettarda angelica is a plant from the Brazilian Caatinga region the roots of which are popularly used for various therapeutic purposes, including veterinary use. The aim of this work was to investigate the in vitro antiviral activity of extracts of plant parts from G. angelica against three animal herpesviruses: bovine (BoHV-1), suid (SuHV-1) and equine (EHV-1) herpesviruses type 1. Materials, Methods & Results: The extracts of roots, leaves and seeds of G. angelica were initially screened for in vitro antiviral activity against these herpesviruses using the virus yield reduction assay. The MDBK cells were used in assays with BoHV-1 and SuHV-1, and the Vero cells with EHV-1. For these assays, the cells previously treated with the extracts in non-cytotoxic concentrations were inoculated with logarithmic dilutions of each virus. The viral inhibitory activity of extracts was calculated by difference of virus titer between treated infected cells and non-treated infected cells. Only the aqueous extract from seeds (AEs) showed a significant antiviral activity (P < 0.01, ANOVA followed by Tukey test) against all herpesviruses leading continuous studies. Thus, the selectivity index (SI) of this extract was determined by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric assay by calculating the ratio CC50 over IC50. The 50% cytotoxic concentration (CC50) was defined as the extract concentration that reduced the cell viability by 50% when compared to untreated controls; the 50% inhibitory concentration (IC50) was defined as the concentration of the extract that inhibited 50% of viral replication when compared to the virus control. The CC50 and IC50 were obtained from nonlinear regression analysis of concentration-effect curves by the GraphPad Prism 5 Demo program and represented the means ± standard deviation of three independent experiments. The CC50 for Vero cells was 400.60 ± 0.20 µg/mL, while the CC50 for MDBK cells was 920.50 ± 0.19 µg/mL. The IC50 values of the AEs on the BoHV-1, SuHV-1 and EHV-1 were 22.79 µg/mL, 91.30 µg/mL and 19.95 µg/mL, respectively. The SI values of this extract for each virus obtained from these data were 40.39, 10.08 and 20.08 for BoHV-1, SuHV-1, and EHV-1, respectively. Discussion: To ensure the antiviral activity of a plant extract and consequently its future use as antiviral agent is crucial the obtainment of its selectivity index or safety index. It is guarantee of a true antiviral effect and not the result of cytotoxicity of the extract on cells, and that could be confused with an antiviral activity. Other important point are the extract IC50 values less than 100 µg/mL. The results of the AEs of G. angelica are in accordance with these considerations indicating that the G. angelica seeds may be a potential source of antiviral compounds insurance and encouraging further investigation of them.

Assuntos

RESUMO

Seven conventional adult horses were inoculated intranasally with a Brazilian A4/72 strain of equid herpesvirus-1 (EHV-1). In the first ten days after the inoculation, they showed signs of a mild, self limitin gupper respiratory tract infection. In spite of the presence of neutralizing antibodies before the trial, seroconversion was observed in some horses. The virus was not isolated from nasal swabs and peripheral blood leukocytes (PBL) of any of the horses. However,the EHV-1 was detected through the polymerase chain reaction (PCR)from PBL of all horses in the experiment within the third to the eighth day after the inoculation that illustrated the viremia. In addition,the PCR assay also detected the virus in bronchoalveolar lavage fluid samples starting on the ninth day after the experimental infection in most of horses. For that reason, as a diagnostic tool, the PCR assay showed higher sensitivity and specificity than the conventional laboratorial methods in detection of EHV-1.

Sete cavalos adultos de status sanitário convencional foram inoculados por via intranasal com a estirpe brasileira A4/72 do herpesvírus eqüino tipo 1 (EHV-1). Nos primeiros dez dias após a inoculação viral, todos os cavalos apresentaram manifestações de infecção respiratória leve erestrita às vias aéreas anteriores. Apesar de possuírem títulos de anticorpos neutralizantes antes da inoculação, alguns cavalos apresentaram soroconversão após o desafio viral. O EHV-1 não foi isolado a partir das secreções nasais e leucócitos sanguíneos periféricos(PBL) de nenhum animal. Entretanto, o DNA viral foi detectado pela reação em cadeia pela polimerase (PCR) nos PBL entre o terceiro e o oitavo dias pós-inoculação (d.p.i.) em todos os animais, indicando a ocorrência de viremia. Além disso, a prova de PCR detectou o vírus nas amostras do lavado broncoalveolar a partir do nono d.p.i. na maioria dos animais. Com base nos resultados obtidos, foi possível concluir que a PCR é uma técnica com alta sensibilidade e especificidade para o diagnóstico do EHV-1, capaz de detectar a presença do DNA viral mesmo quando não ocorre a constatação do agente pelos métodos tradicionais.

Assuntos

RESUMO

Seven conventional adult horses were inoculated intranasally with a Brazilian A4/72 strain of equid herpesvirus-1 (EHV-1). In the first ten days after the inoculation, they showed signs of a mild, self limitin gupper respiratory tract infection. In spite of the presence of neutralizing antibodies before the trial, seroconversion was observed in some horses. The virus was not isolated from nasal swabs and peripheral blood leukocytes (PBL) of any of the horses. However,the EHV-1 was detected through the polymerase chain reaction (PCR)from PBL of all horses in the experiment within the third to the eighth day after the inoculation that illustrated the viremia. In addition,the PCR assay also detected the virus in bronchoalveolar lavage fluid samples starting on the ninth day after the experimental infection in most of horses. For that reason, as a diagnostic tool, the PCR assay showed higher sensitivity and specificity than the conventional laboratorial methods in detection of EHV-1.(AU)

Sete cavalos adultos de status sanitário convencional foram inoculados por via intranasal com a estirpe brasileira A4/72 do herpesvírus eqüino tipo 1 (EHV-1). Nos primeiros dez dias após a inoculação viral, todos os cavalos apresentaram manifestações de infecção respiratória leve erestrita às vias aéreas anteriores. Apesar de possuírem títulos de anticorpos neutralizantes antes da inoculação, alguns cavalos apresentaram soroconversão após o desafio viral. O EHV-1 não foi isolado a partir das secreções nasais e leucócitos sanguíneos periféricos(PBL) de nenhum animal. Entretanto, o DNA viral foi detectado pela reação em cadeia pela polimerase (PCR) nos PBL entre o terceiro e o oitavo dias pós-inoculação (d.p.i.) em todos os animais, indicando a ocorrência de viremia. Além disso, a prova de PCR detectou o vírus nas amostras do lavado broncoalveolar a partir do nono d.p.i. na maioria dos animais. Com base nos resultados obtidos, foi possível concluir que a PCR é uma técnica com alta sensibilidade e especificidade para o diagnóstico do EHV-1, capaz de detectar a presença do DNA viral mesmo quando não ocorre a constatação do agente pelos métodos tradicionais.(AU)

Assuntos

RESUMO

ABSTRACT This report describes the first Brazilian equine herpesvirus type 1 (EHV-1) isolation from a single fatal equine herpes myeloencephalopathy case in a mare. The isolation of EHV-1 was confirmed from the first passage of cerebrospinal fluid (CSF) sample in Vero cells by PCR and virus neutralization assay. As virus isolation from CSF is unlikely to be successful, as has been shown in several case reports, this circumstantial evidence suggests that the neurological disease was caused by particularly neurovirulent strain of EHV-1.

RESUMO O presente relato refere-se ao primeiro isolamento no Brasil do herpesvírus eqüino tipo 1 (HVE-1) proveniente de um caso clínico de mieloncefalopatia herpética em uma égua, que evoluiu para o óbito. O isolado do HVE-1, denominado 07/05, foi obtido a partir de uma amostra de líquor na primeira passagem em células Vero, confirmando-se sua identidade pela PCR e pela prova de neutralização viral. Como o isolamento viral a partir do líquor geralmente não é bem sucedido, conforme demonstrado em vários relatos de casos, o presente achado sugere que a doença neurológica foi causada por uma amostra particularmente neurovirulenta de HVE-1.